Previous studies have also shown that SIRT1 heterozygous deficient mice exhibited exacerbated HFD-induced hepatic steatosis and inflammation as well as insulin resistance (Xu et al., 2016b; Xu et al., 2010). Here, SIRT1 is linked to fatty liver disease.